Cargando…
Lentiviral vector-mediated co-overexpression of VEGF and Bcl-2 improves mesenchymal stem cell survival and enhances paracrine effects in vitro
Mesenchymal stem cell (MSC) transplantation has emerged as a promising therapy for ischemic heart disease; however, the low survival rate of transplanted cells limits their therapeutic efficacy. The aim of this study was to investigate whether the dual genetic modification of vascular endothelial gr...
Autores principales: | Ni, Xiaobin, Ou, Caiwen, Guo, Jingbin, Liu, Bei, Zhang, Jianwu, Wu, Zhiye, Li, Hekai, Chen, Minsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505017/ https://www.ncbi.nlm.nih.gov/pubmed/28627637 http://dx.doi.org/10.3892/ijmm.2017.3019 |
Ejemplares similares
-
Treatment of Myocardial Infarction with Gene-modified Mesenchymal Stem Cells in a Small Molecular Hydrogel
por: Wu, Zhiye, et al.
Publicado: (2017) -
Dual-ligand supramolecular nanofibers inspired by the renin-angiotensin system for the targeting and synergistic therapy of myocardial infarction
por: Wen, Zhanpeng, et al.
Publicado: (2021) -
Promoter Optimization Circumvents Bcl-2 Transgene-Mediated Suppression of Lentiviral Vector Production
por: Kok, Cindy Y., et al.
Publicado: (2023) -
Production of lentiviral vectors
por: Merten, Otto-Wilhelm, et al.
Publicado: (2016) -
Lentiviral Vector Bioprocessing
por: Perry, Christopher, et al.
Publicado: (2021)